Ingalls & Snyder LLC Abbott Laboratories Transaction History

Ingalls & Snyder LLC

  • $2.56 Billion
  • Q3 2024

A detailed history of Ingalls & Snyder LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ingalls & Snyder LLC holds 246,630 shares of ABT stock, worth $28.1 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
246,630
Previous 246,912 0.11%
Holding current value
$28.1 Million
Previous $25.7 Million 9.59%
% of portfolio
1.1%
Previous 1.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$100.07 - $118.13 $28,219 - $33,312
-282 Reduced 0.11%
246,630 $28.1 Million
Q2 2024

Jul 31, 2024
BUY
$100.73 - $112.44 $5.56 Million - $6.2 Million
55,152 Added 28.76%
246,912 $25.7 Million
Q1 2024

May 13, 2024
BUY
$109.52 - $120.96 $299,099 - $330,341
2,731 Added 1.44%
191,760 $21.8 Million
Q4 2023

Jan 29, 2024
BUY
$90.19 - $110.4 $3.12 Million - $3.82 Million
34,586 Added 22.39%
189,029 $20.8 Million
Q3 2023

Nov 02, 2023
BUY
$95.53 - $114.62 $8,215 - $9,857
86 Added 0.06%
154,443 $15 Million
Q2 2023

Jul 27, 2023
SELL
$100.78 - $112.29 $119,323 - $132,951
-1,184 Reduced 0.76%
154,357 $16.8 Million
Q1 2023

May 09, 2023
SELL
$96.86 - $114.01 $100,928 - $118,798
-1,042 Reduced 0.67%
155,541 $15.8 Million
Q4 2022

Jan 31, 2023
SELL
$95.06 - $111.52 $107,132 - $125,683
-1,127 Reduced 0.71%
156,583 $17.2 Million
Q3 2022

Oct 21, 2022
SELL
$96.76 - $112.03 $175,329 - $202,998
-1,812 Reduced 1.14%
157,710 $15.3 Million
Q2 2022

Aug 11, 2022
SELL
$102.07 - $123.37 $524,333 - $633,751
-5,137 Reduced 3.12%
159,522 $17.3 Million
Q1 2022

May 09, 2022
SELL
$114.02 - $139.04 $91,101 - $111,092
-799 Reduced 0.48%
164,659 $19.5 Million
Q4 2021

Feb 11, 2022
SELL
$115.53 - $141.46 $1.58 Million - $1.94 Million
-13,691 Reduced 7.64%
165,458 $23.3 Million
Q3 2021

Oct 27, 2021
SELL
$116.66 - $129.06 $1.59 Million - $1.76 Million
-13,648 Reduced 7.08%
179,149 $21.2 Million
Q2 2021

Aug 03, 2021
SELL
$105.79 - $124.53 $406,233 - $478,195
-3,840 Reduced 1.95%
192,797 $22.4 Million
Q1 2021

Apr 21, 2021
SELL
$108.84 - $128.23 $863,318 - $1.02 Million
-7,932 Reduced 3.88%
196,637 $23.6 Million
Q4 2020

Jan 27, 2021
BUY
$105.0 - $114.42 $21.5 Million - $23.4 Million
204,569 New
204,569 $22.4 Million
Q3 2020

Oct 21, 2020
SELL
$91.64 - $111.29 $18.7 Million - $22.7 Million
-204,247 Closed
0 $0
Q2 2020

Jul 31, 2020
BUY
$76.57 - $98.0 $7,274 - $9,310
95 Added 0.05%
204,247 $18.7 Million
Q1 2020

Apr 22, 2020
BUY
$62.82 - $91.86 $12.8 Million - $18.8 Million
204,152 New
204,152 $16.1 Million
Q4 2019

Jan 15, 2020
SELL
$78.51 - $87.4 $15.5 Million - $17.3 Million
-197,448 Closed
0 $0
Q3 2019

Oct 16, 2019
SELL
$81.84 - $88.74 $797,448 - $864,682
-9,744 Reduced 4.7%
197,448 $16.5 Million
Q2 2019

Jul 11, 2019
SELL
$72.88 - $85.0 $1.59 Million - $1.85 Million
-21,796 Reduced 9.52%
207,192 $17.4 Million
Q1 2019

Apr 11, 2019
SELL
$66.22 - $80.06 $195,547 - $236,417
-2,953 Reduced 1.27%
228,988 $18.3 Million
Q4 2018

Jan 24, 2019
SELL
$65.56 - $74.27 $755,054 - $855,367
-11,517 Reduced 4.73%
231,941 $16.8 Million
Q3 2018

Oct 24, 2018
SELL
$60.81 - $73.36 $111,403 - $134,395
-1,832 Reduced 0.75%
243,458 $17.9 Million
Q2 2018

Aug 10, 2018
SELL
$57.57 - $63.54 $256,186 - $282,753
-4,450 Reduced 1.78%
245,290 $15 Million
Q1 2018

Apr 17, 2018
SELL
$56.27 - $63.62 $4,895 - $5,534
-87 Reduced 0.03%
249,740 $15 Million
Q4 2017

Jan 19, 2018
BUY
$53.68 - $57.47 $13.4 Million - $14.4 Million
249,827
249,827 $14.3 Million

Others Institutions Holding ABT

# of Institutions
3,187
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email